Common Stock - Additional Information (Details) - USD ($)	1 Months Ended		6 Months Ended	12 Months Ended
	Oct. 31, 2021	Apr. 30, 2020	Jun. 30, 2024	Dec. 31, 2023
Class of Stock [Line Items]
Common stock, shares authorized			300,000,000	300,000,000
Common stock, par value			$ 0.0001	$ 0.0001
Common stock voting rights			one vote per share
Common stock dividend			$ 0	$ 0
Funding Agreement | Cystic Fibrosis Foundation
Class of Stock [Line Items]
Additional funding upon acceptance of investigational New Drug application	$ 4,000,000	$ 4,000,000
Additional investment in cash	$ 4,000,000
Funding Agreement | Cystic Fibrosis Foundation | Common Stock
Class of Stock [Line Items]
Number of shares sold and issued	125,715
Funding Agreement | Cystic Fibrosis Foundation | Series C Redeemable Convertible Preferred Stock
Class of Stock [Line Items]
Investment in redeemable convertible preferred stock financing		$ 10,000,000